Manufacturer record
Orchid Medlife Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Orchid Medlife Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2024 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TD250606, Zinc Acetate Dispersable Tablets 20 mg (exp Mar 2027). Office of Drugs Controller, Meghalaya (state lab) found it not of standard quality: The sample is not of standard quality for the reason stated under "Description" of the tablets. Listed in the February 2026 alert.
Records by type
4 records linked to Orchid Medlife Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Zinc Acetate Dispersable Tablets 20 mg | Batch TD250606Mfg Apr 2025 · Exp Mar 2027 | The sample is not of standard quality for the reason stated under "Description" of the tabletsDescription | Office of Drugs Controller, MeghalayaState lab | Feb 2026 |
| Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP | Batch TA250025Mfg Jan 2025 · Exp Dec 2026 | Dissolution (Montelukast Sodium)Dissolution | SDTL, GuwahatiState lab | Dec 2025 |
| Ibuprofen Tablets IP 400mg | Batch TF240782Mfg Jun 2024 · Exp Aug 2026 | Sample does not conform to claim as per I.P. 2022 w.r.t. Dissolution of Ibuprofen.Dissolution | DTL BaddiState lab | Apr 2025 |
| Rabeprazole Sodium Gastro-Resistant Tablets IP 20 mg (Rben-20 Tablets) | Batch TJ231109Mfg Oct 2023 · Exp Sep 2025 | Dissolution (Buffer stage)Dissolution | RDTL ChandigarhState lab | Mar 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.